Peptide directoryBrain, hypothalamus & pituitary

Agouti-related peptide

The hunger neuron’s blocker of the fullness receptor.

Where it comes from

Made in
The NPY/AgRP neurons of the arcuate nucleus, and the adrenal
Sent out by
Fasting and ghrelin switch the neurons on; leptin, insulin and PYY switch them off
Acts on
  • MC4R neurons of the paraventricular nucleus
  • Other melanocortin targets

What it does

  • Blocks alpha-MSH, so the fullness signal cannot get through: hunger 1
  • A single dose drives feeding for days, far longer than NPY 1
  • The AgRP neurons are the hunger neurons; activating them makes a fed mouse eat, silencing them in adults starves it 2

In medicine

  • No medicine copies it or blocks it. Blood AgRP rises with fasting and is a research marker
  • Setmelanotide works below the level at which AgRP acts: it activates MC4R directly, so the blockade AgRP imposes does not stand in its way. It is approved for obesity caused by faults in the melanocortin pathway 3

Beyond the body’s own use

  • AgRP is studied in anorexia nervosa and in cachexia, conditions in which appetite is lost, and from the other direction in obesity; no AgRP preparation or blocker has been given to a person 1
  • Nothing containing AgRP is approved or obtainable outside the laboratory
  • The clearest evidence of how much it matters comes from its neurons rather than the peptide: silencing the AgRP neurons of an adult mouse stops it eating altogether, while the same neurons can be removed in a newborn with little effect 2

Sources

  1. Ollmann et al., Antagonism of central melanocortin receptors by agouti-related protein, Science 1997
  2. Luquet et al., NPY/AgRP neurons are essential for feeding in adult mice, Science 2005
  3. Clément et al., Efficacy and safety of setmelanotide in severe obesity due to LEPR or POMC deficiency, Lancet Diabetes and Endocrinology 2020

This card describes what a medicine is for and what the evidence says; it recommends nothing. Talk to your clinician about anything you read here.